Lymphatic system-directing lipid prodrugs
US12178875B2 · kind B2 · utility
0Cited by
15References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 29, 2024 |
| Grant date | Dec 31, 2024 |
| Priority date | — |
| Expiry date | Jan 29, 2044 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides lymphatic system-directing lipid prodrugs, pharmaceutical compositions thereof, methods of producing such prodrugs and compositions, as well as methods of improving the bioavailability or other properties of a therapeutic agent that comprises part of the lipid prodrug. The present invention also provides methods of treating a disease, disorder, or condition such as those disclosed herein, comprising administering to a patient in need thereof a provided lipid prodrug or a pharmaceutical composition thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.